Logo
Extra Body Filler S

Extra Body Filler S

Extra

Body filler
  • Approved by the KFDA (Korean authorities) as a body filler based on cross Linked hyaluronic acid for body contouring applications.
  • Manufactured in South Korea with EP Grade raw materials and purified using MDAWO technology to achieve high purity and low residual cross Linker and endotoxin levels.
  • Distributed internationally as a professional Use body filler classified as a medical device or injectable aesthetic product, depending on local regulations.
  • Marketed in the EU and other regions through professional distributors who require purchasers to be medical professionals, in line with medical device and professional Use cosmetic regulations.
  • Practitioners are expected to comply with local laws, regulatory requirements and professional guidelines for the use of breast and body HA fillers.
Hyaluronic acid body contouring filler for breast augmentation

Description

Extra Body Filler S (Extra S 10mL Body Filler) is a hyaluronic acid-based body filler specifically designed for non-surgical body contouring, particularly breast enhancement. It contains 20 mg/mL of highly purified, cross-linked hyaluronic acid formulated as patented microbeads using TSC (Third Step Crosslinking) technology, which increases gel viscosity, stability and longevity in tissue. The filler is supplied as a 10 mL pre-filled syringe without lidocaine and is intended for deep dermal to subcutaneous injection by qualified medical professionals. Extra S increases the projection and fullness of the breasts, fills hollow or depressed body areas and improves the overall balance and contour of the figure. The gel is soft, highly viscoelastic and easily moldable, allowing natural-looking shaping with durable results. The product is manufactured with EP-grade raw materials, purified to approximately 97% using MDAWO (Multiple-Degree Amphiphilic Wash-Out) technology, and uses DVS (divinyl sulfone) as the cross-linking agent instead of BDDE, with residuals removed during purification. It is KFDA-approved for body contouring and recognized internationally as a long-lasting, high-viscosity body filler.

Bnefits

  • Hyaluronic acid-based body filler designed specifically for body contouring, especially breast enhancement.
  • Patented microbead, cross-linked HA structure provides strong viscosity and high viscoelasticity for durable volume and shape.
  • Uses TSC (Third Step Crosslinking) technology with ultra-fine bead particles to increase cross-linking rate and gel stability.
  • 20 mg/mL hyaluronic acid concentration provides substantial volumising capacity in each 10 mL syringe.
  • Soft, easily moldable monophasic gel allows precise contouring and natural-looking results.
  • Helps increase the projection and fullness of the breasts and improve overall body balance and symmetry.
  • Can fill hollow or depressed areas, reduce the appearance of cellulite and support contouring of neck and décolletage.
  • Manufactured with EP-grade raw materials from reputable suppliers and purified to around 97% to minimise endotoxins and residual cross-linker.
  • Designed to provide long-lasting effects, typically in the range of several months up to around a year depending on indication and treatment plan.
  • Lidocaine-free formulation, suitable for use with separate local anaesthesia techniques according to practitioner preference.

Indications

  • Non-surgical breast augmentation and cleavage enhancement using hyaluronic acid body filler.
  • Body contouring and augmentation of soft-tissue areas requiring volume and improved shape.
  • Correction of hollow or depressed areas of the body (e.g., contour defects, mild asymmetries) as judged appropriate by the practitioner.
  • Improvement of overall body balance and figure symmetry in aesthetic body contouring.
  • Reduction in the visible appearance of cellulite by filling subcutaneous depressions.
  • Prevention or softening of sagging skin and lines in the neck and décolletage, when used as part of a comprehensive treatment plan for those areas.

Composition

  • Active ingredient: Hyaluronic acid (HA) 20 mg/mL, purified and cross-linked.
  • Form: Ultra-fine, monophasic, soft gel microbeads with high viscoelasticity.
  • Cross-linking technology: TSC (Third Step Crosslinking) process to increase viscosity and cross-linking density.
  • Cross-linking agent: Divinyl sulfone (DVS), used in place of BDDE; residuals are removed during the purification process.
  • Purity: Approximately 97% purified gel using MDAWO (Multiple-Degree Amphiphilic Wash-Out) technology to reduce endotoxin and residual cross-linker levels.
  • Particle size: Approximately 250 µm (as specified for Extra S body filler).
  • Lidocaine: None (lidocaine-free formulation).
  • Excipients: EP-grade excipients and buffer components suitable for injectable HA gel (specific proprietary formulation not fully disclosed).

Formulation

  • Hyaluronic acid-based injectable body filler for deep dermal and subcutaneous use.
  • Monophasic, soft, high-viscosity gel with ultra-fine cross-linked HA microbeads.
  • 20 mg/mL HA concentration designed for body contouring rather than facial fine-line correction.
  • No lidocaine included; analgesia must be provided separately if required.
  • Engineered via TSC cross-linking and MDAWO purification for high stability, low impurity levels and long-lasting effect.
  • Intended exclusively for professional use by trained medical practitioners experienced in body filler procedures.

Packaging

  • 1 x 10 mL pre-filled syringe of Extra S body filler per unit.
  • Supplied as a body filler product for single-patient, single-use application.
  • Typically packaged with compatibility information for recommended needle/cannula sizes (21–23G, 50 mm cannula).
  • Outer carton labelled with product name (Extra S / Extra Body Filler S), batch number, expiry date and manufacturer details.

Usage

  • For use only by suitably trained and licensed medical professionals familiar with body filler techniques and breast/body contouring.
  • Before use, inspect the packaging and syringe; do not use if packaging is damaged, the syringe is compromised or the product is past its expiry date.
  • Administer under appropriate aseptic conditions in a clinical environment, with full patient assessment, consent and documentation.
  • Typical injection plane: deep dermis to subcutaneous tissue, depending on the treated area and technique.
  • Recommended needle/cannula: 21–23G, approximately 50 mm cannula for breast and body contouring, according to the manufacturer’s specifications.
  • For breast augmentation, follow established body filler protocols, taking care to avoid the mammary gland; product literature suggests that a total of around 50 mL per breast treatment course may be used depending on the desired result and clinical judgment.
  • Inject slowly, in small aliquots, using fan, linear or depot techniques as appropriate, and gently mold the gel to achieve the desired contour.
  • Do not inject intravascularly; aspirate where appropriate and observe for any signs of vascular compromise.
  • After injection, gently massage and contour the treated area to ensure even distribution and a smooth profile.
  • Advise the patient on post-procedure care, including avoiding pressure or trauma to the treated area, limiting strenuous exercise for a short period, and monitoring for signs of complications.
  • Treatment should not be performed in patients who are not suitable candidates for breast/body HA fillers, and it should never replace oncologic or diagnostic evaluation of breast tissue.
  • Follow local guidelines and best practice recommendations for breast/body fillers, including discussing potential interference with future breast imaging (e.g., mammography) with patients before treatment.

Contraindications

  • Known hypersensitivity or allergy to hyaluronic acid or any component of the filler formulation.
  • Active skin infections, inflammatory lesions or open wounds at or near the intended injection site.
  • Current or previous malignancy or suspicious lesions in the breast or treatment area without prior thorough medical evaluation and clearance.
  • History of severe allergic or anaphylactic reactions to injectable fillers.
  • Pregnancy or breastfeeding, due to limited safety data for body/breast HA fillers in these populations.
  • Bleeding disorders or use of significant anticoagulant/antiplatelet therapy that increases the risk of bleeding or hematoma, unless carefully assessed and medically cleared.
  • Existing breast implants, fat grafts or significant breast tissue irregularities where interference with imaging or clinical assessment could pose additional risk, unless managed within a multidisciplinary medical framework.
  • Autoimmune disease or significant immunosuppression where wound healing or response to foreign materials may be altered, without prior specialist consultation.
  • Use in patients under the minimum legal age for cosmetic procedures in the relevant jurisdiction.

Adverse Effects

  • Common, usually transient effects: redness, swelling, tenderness, bruising and mild pain at the injection site.
  • Temporary asymmetry or irregularities in contour, which may require manual molding or additional corrective treatment.
  • Nodules or palpable lumps if product is not evenly distributed or if excessive volume is placed in one area.
  • Local infection at the injection site if aseptic technique is not strictly followed.
  • Hypersensitivity or allergic-type reactions, including erythema, pruritus or swelling beyond expected post-procedural responses.
  • Vascular compromise (rare but serious), including blanching, severe pain, skin discolouration or necrosis if inadvertent intravascular injection or compression occurs; urgent management is required if suspected.
  • Potential interference with breast imaging (e.g., mammography), as hyaluronic acid deposits can obscure or mimic lesions; this should be discussed with patients in advance and documented.
  • Any unexpected or severe adverse effect should prompt immediate clinical assessment and consideration of hyaluronidase treatment or referral to appropriate medical specialists.

Storage Conditions

  • Store in accordance with instructions on the product packaging, typically in a cool, dry place away from direct sunlight.
  • Most HA fillers are stored at controlled room temperature (commonly around 2–25 °C); do not freeze unless explicitly allowed on the label.
  • Keep the syringe in its original, sealed blister and outer carton until use to maintain sterility and protect from physical damage.
  • Do not use after the expiration date printed on the packaging.
  • Keep out of reach of children and unauthorised persons.
  • Do not re-sterilise or reuse; this is a single-use sterile product.

Duration

The stated duration of effect for Extra S 10 mL Body Filler is typically around 7 to 12 months with regular sessions, although actual longevity depends on treatment area, injection technique, patient metabolism and lifestyle. Many protocols consider periodic maintenance treatments to sustain volume and contour over time.

Onset

Results are visible immediately after injection because the gel physically occupies volume in the treated area. Final shape and integration typically stabilise over several days to a few weeks as swelling subsides and the filler settles in the tissue.

Browse more Body filler

Top Treatments

Top Cities in the UK